Glenn Dranoff of the Cancer Vaccine Center at Dana-Farber Cancer Institute opened "Therapeutic Cancer Vaccines: Renewed Optimism for the Product Pipeline" at BIO 2012 with a positive note: "It's an exciting time for immunotherapy."
The New York Genome Center has won a grant to fuel its ambitious plans to establish one of the country's leading genomics institutes in Manhattan.
UC San Diego officials have unveiled ambitious plans to erect a sparkling new facility to house life sciences startups and academics focused on cancer research.
4s3 Bioscience in Medford, MA, recently raised $20 million in Series A financing to fuel its drug delivery technology to treat muscle disorders. As Xconomy reports, the cash comes from KLP Enterprises; Karen Pritzker, of the Hyatt hotel chain Pritzker family, formed the trust.
India is looking for drug plant inspectors. It wants to reach its full planned complement of 1,364--864 of which are currently on the job--and begin inspecting foreign plants. But even that's not
Aileron Therapeutics' stapled peptide platform has won over Roche, which is paying $25 million upfront and up to $1.1 billion more in milestones to explore the potential to deliver a new generation
Seattle-based Northstar Neuroscience is opting to liquidate its assets, terminating all but a skeleton staff to handle the dissolution of the company. Northstar's stock plunged in early 2007 after
Novartis presented positive mid-stage data for NVA237, a lung disease treatment, at the annual European Respiratory Society (ERS) show in Berlin, Germany. Novartis licensed the drug for from Sosei
Neurogen has suspended dosing in a Phase II/III trial of its insomnia drug adipiplon after registering next day side effects. Researchers had been dosing patients with various amounts of immediate
Australian officials have approved a bid flu vaccine developed by CSL. And the government announced a $160 million budget to stockpile additional vaccines to help protect the country from an